About Jimena Vicencio
Articles by Jimena Vicencio, MD
FDA Approves Iberdomide (Zenbexus) With Daratumumab and Dexamethasone for Multiple MyelomaAug 13, 2026
Diversity and Representation in Cancer Clinical TrialsAug 12, 2026
What is Childhood MDS?Aug 12, 2026
How Depression Can Make Cancer Treatment Harder to FollowAug 06, 2026
How Acupuncture Can Support Cancer Pain ManagementAug 05, 2026
Study Shows Affordable Care Act (ACA) Has Improved Access to First-Line Treatment for MDS with 5q DeletionAug 04, 2026
What High White Blood Cell Counts Mean in MyelofibrosisAug 04, 2026
Study Reveals 30-Year Trends in Cancer Clinical Trial DiversityJul 31, 2026
Do Autoimmune Diseases Impact Side Effect Risk During Immunotherapy Treatment?Jul 31, 2026
The Link Between Pre-Treatment Fatigue and Treatment Side EffectsJul 28, 2026
Understanding Cancer-Related Fatigue: How to Manage this Common Side EffectJul 28, 2026
Cyclospora Outbreak: What People with Cancer Should KnowJul 18, 2026
Exploring Nutrition in Myeloma Care: Join the NUTRIVENTION-5 TrialJul 17, 2026
Understanding Phlebotomies: A Guide for People with Polycythemia VeraJul 16, 2026
When Your Gut Needs a Rest: Navigating Cancer Treatment Side Effects with the BRAT DietJul 13, 2026
Can an Anti-Inflammatory Diet Help Reduce Nerve Pain After Chemotherapy?Jul 10, 2026
Introducing Earlier Supportive Care Can Help Improve Symptoms and Side Effects for People with Multiple MyelomaJul 06, 2026
New Genetic Test May Improve Accuracy of MDS Risk AssessmentJul 06, 2026
FDA Approves New Immunotherapy to Improve Stem Cell Transplant Success in Blood Cancer PatientsJul 02, 2026
How Traditional Chinese Medicine Can Be Used in Cancer CareJun 26, 2026
Luspatercept Shows Long-Term Survival Benefit and Transfusion Independence After 3-Year Follow-UpJun 25, 2026
New Type II JAK2 Inhibitor AJ1-11095 for Myelofibrosis is moving to phase 2 trialsJun 22, 2026
How Income and Insurance Impact Cancer Care CommunicationJun 15, 2026
How People with Cancer View Their Caregivers' StressJun 11, 2026